Skip to main content
Fig. 2 | Acta Neuropathologica Communications

Fig. 2

From: High diagnostic performance of independent alpha-synuclein seed amplification assays for detection of early Parkinson’s disease

Fig. 2

Seed amplification assay diagnostic performance for early PD. a Plots of sensitivity (left) and specificity (right) for SAA by each of the three laboratories (AbbVie, Amprion, and Caughey) at BL and Y3. Values (percentages) are provided for sensitivity and specificity in the tables below the respective plots. Calculations for Amprion αSyn-SAA are reported when 2 inconclusive results are excluded (filled circles), or when they are included as negative results (open circles). Amprion αSyn-SAA sensitivity is 96% if two inconclusive results (only 2/3 positive replicates) are excluded from analysis (filled circles), but 89% if these are treated as negative (not meeting 3/3 criterion for positive result). Specificity calculation and year 3 results were not affected. b Plots for area under the curve (AUC), positive predictive value (PPV), and negative predictive value (NPV). ‡ Inconclusive results (2 samples at baseline) not included in calculation

Back to article page